In addition, the percentage of PD-L2 expression on CD14+ (PD-L2+CD14+) monocytes was lower in the LTBI-non-CKD group than in the HC group (50.4 ± 27.2 vs. 69.0 ± 28.3, p = 0.025). Here, CD14 is linked to chronic kidney disease.